Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | SRA Run Selector | Joanna Achinger-Kawecka | ||||||
GSE73782 |
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [Hi-C]
|
13 | Joanna Achinger-Kawecka | Apr 04, 2016 | ||||
GSE73783 |
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [ChIP-seq]
|
3 |
|
Joanna Achinger-Kawecka | Apr 04, 2016 | |||
GSE73784 |
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq]
|
6 |
|
Joanna Achinger-Kawecka | Apr 04, 2016 | |||
GSE118711 |
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [ChIP-seq]
|
14 |
|
Joanna Achinger-Kawecka | Dec 11, 2019 | |||
GSE118712 |
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [Hi-C]
|
9 | Joanna Achinger-Kawecka | Dec 11, 2019 | ||||
GSE118713 |
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq]
|
9 |
|
Joanna Achinger-Kawecka | Dec 11, 2019 | |||
GSE118714 |
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [WGBS]
|
3 | Joanna Achinger-Kawecka | Dec 11, 2019 | ||||
GSE118715 |
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [WGS]
|
5 |
|
Joanna Achinger-Kawecka | Dec 11, 2019 | |||
GSE130916 |
Deregulation of the three-dimensional epigenome in endocrine resistant breast cancer
|
6 | Joanna Achinger-Kawecka | Dec 11, 2019 | ||||
GSE150252 |
BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer
|
12 |
|
Joanna Achinger-Kawecka | Feb 10, 2021 | |||
GSE171070 |
Epigenetic therapy suppresses tumour growth by rewiring ER-mediated long-range chromatin interactions in ER+ endocrine-resistant breast cancer [ChIP-seq]
|
23 |
|
Joanna Achinger-Kawecka | Dec 12, 2021 | |||
GSE171071 |
Epigenetic therapy suppresses tumour growth by rewiring ER-mediated long-range chromatin interactions in ER+ endocrine-resistant breast cancer [HiC]
|
6 | Joanna Achinger-Kawecka | Dec 12, 2021 | ||||
GSE171072 |
Epigenetic therapy suppresses tumour growth by rewiring ER-mediated long-range chromatin interactions in ER+ endocrine-resistant breast cancer [PCHiC]
|
6 |
|
Joanna Achinger-Kawecka | Dec 12, 2021 | |||
GSE171073 |
Epigenetic therapy suppresses tumour growth by rewiring ER-mediated long-range chromatin interactions in ER+ endocrine-resistant breast cancer [RNA-seq]
|
16 |
|
Joanna Achinger-Kawecka | Dec 12, 2021 |